Abstract
One of the most relevant goals of the musculoskeletal care in hemophilia is to prevent intraarticular bleeding. In the past, usual clinical practice allowed for a tacit, moderate degree of tolerance for sporadic intraarticular hemorrhages, based on the clinical observation that joints were able to tolerate an infrequent bleed with little or no harm. However, increasing knowledge on the pathophysiology of hemarthrosis in vitro and in vivo, as well as in clinical experiments, indicates that we need to move towards a more stringent policy with regards to the prevention of occasional and subclinical intraarticular hemorrhages [1-3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
